PriceTargets.com logo

Clarivate - CLVT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $13.88
  • Forecasted Upside: 47.76%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$9.39 As of 03/31/2023 01:00 AM ET
▲ +0.12 (1.29%)

This chart shows the closing price for CLVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Clarivate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLVT

Analyst Price Target is $13.88
▲ +47.76% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Clarivate in the last 3 months. The average price target is $13.88, with a high forecast of $15.00 and a low forecast of $12.00. The average price target represents a 47.76% upside from the last price of $9.39.

This chart shows the closing price for CLVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Clarivate. This rating has held steady since August 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/8/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/2/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/15/2023Bank of AmericaInitiated CoverageNeutral ➝ NeutralLow
3/10/2023Royal Bank of CanadaReiterated RatingOutperform$14.00N/A
3/2/2023Wells Fargo & CompanyBoost TargetOverweight$14.00 ➝ $15.00Low
3/2/2023Royal Bank of CanadaBoost TargetOutperform$12.00 ➝ $14.00Low
2/6/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$11.00 ➝ $12.00Low
1/4/2023Morgan StanleyLower TargetOverweight$13.00 ➝ $11.00Low
11/9/2022Wells Fargo & CompanyLower TargetOverweight$15.00 ➝ $14.00Low
11/9/2022The Goldman Sachs GroupLower TargetBuy$17.00 ➝ $14.50Low
11/9/2022Morgan StanleyLower TargetOverweight$14.00 ➝ $13.00Low
11/9/2022Royal Bank of CanadaLower TargetOutperform$13.00 ➝ $12.00Low
10/7/2022Wells Fargo & CompanyLower TargetOverweight$18.00 ➝ $15.00Low
9/28/2022Royal Bank of CanadaLower Target$16.00 ➝ $13.00Low
9/27/2022Morgan StanleyLower TargetOverweight$15.00 ➝ $14.00Low
9/13/2022Morgan StanleyLower TargetOverweight$16.00 ➝ $15.00Low
8/10/2022Morgan StanleyLower TargetOverweight$17.00 ➝ $16.00Low
7/12/2022Wells Fargo & CompanyInitiated CoverageOverweight$20.00Low
7/1/2022Royal Bank of CanadaLower TargetOutperform$23.00 ➝ $18.00Low
5/26/2022Morgan StanleyLower TargetOverweight$18.00 ➝ $17.00Low
4/19/2022The Goldman Sachs GroupLower TargetBuy$23.00 ➝ $20.00High
3/11/2022Morgan StanleyLower TargetOverweight$20.00 ➝ $19.00Medium
2/7/2022Morgan StanleyLower TargetOverweight$28.00 ➝ $20.00Medium
2/4/2022CitigroupDowngradeBuy ➝ Neutral$35.00 ➝ $16.00Low
2/3/2022BarclaysDowngradeOverweight ➝ Equal Weight$25.00 ➝ $16.00Low
1/18/2022BarclaysLower Target$30.00 ➝ $25.00High
12/21/2021CitigroupInitiated CoverageBuy$35.00Medium
12/13/2021The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$29.00High
12/2/2021Morgan StanleyBoost TargetOverweight$27.00 ➝ $28.00High
9/30/2021Morgan StanleyLower TargetOverweight$30.00 ➝ $28.00Low
8/16/2021Bank of AmericaInitiated CoverageBuy$28.00High
7/30/2021Morgan StanleyLower TargetOverweight$32.00 ➝ $30.00Low
5/18/2021Morgan StanleyBoost TargetOverweight$30.00 ➝ $32.00Medium
4/30/2021Morgan StanleyBoost TargetOverweight$28.00 ➝ $30.00High
4/30/2021B. RileyBoost TargetBuy$30.00 ➝ $33.00High
3/31/2021Jefferies Financial GroupInitiated CoverageBuy$30.00High
3/15/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$28.00High
3/11/2021CitigroupInitiated CoverageBuy$36.00Low
3/8/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$28.00Medium
3/4/2021Morgan StanleyLower TargetEqual Weight ➝ Overweight$30.00 ➝ $28.00N/A
2/26/2021Morgan StanleyLower TargetEqual Weight$30.00 ➝ $28.00High
(Data available from 4/1/2018 forward)

News Sentiment Rating

0.95 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/3/2022
  • 8 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
10/3/2022
  • 8 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/2/2022
  • 5 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/2/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/1/2023
  • 7 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/31/2023
  • 16 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 8 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023

Current Sentiment

  • 8 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Clarivate logo
Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Life Sciences and Healthcare (LS&H), and Intellectual Property (IP). The A&G segment consists of products and services to organizations that plan, fund, implement, and utilize education and research at a global, national, institutional, and individual level. The LS&H segment comprises of products and solutions that provide insight and foresight across the drug and device lifecycle, empowering life science and healthcare organizations. The IP segment refers to patent intelligence, brand IP Intelligence, and IP Lifecycle Management product groups, which enables customers to establish, protect, and manage their intellectual property and form critical business decision while also mitigating risk and improving efficiencies. The company was founded in 1864 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $9.39
Low: $9.27
High: $9.46

50 Day Range

MA: $10.47
Low: $9.07
High: $11.68

52 Week Range

Now: $9.39
Low: $7.85
High: $17.50

Volume

3,788,422 shs

Average Volume

5,738,801 shs

Market Capitalization

$6.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Clarivate?

The following Wall Street sell-side analysts have issued reports on Clarivate in the last twelve months: Bank of America Co., Morgan Stanley, Royal Bank of Canada, The Goldman Sachs Group, Inc., TheStreet, and Wells Fargo & Company.
View the latest analyst ratings for CLVT.

What is the current price target for Clarivate?

4 Wall Street analysts have set twelve-month price targets for Clarivate in the last year. Their average twelve-month price target is $13.88, suggesting a possible upside of 47.8%. Wells Fargo & Company has the highest price target set, predicting CLVT will reach $15.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $12.00 for Clarivate in the next year.
View the latest price targets for CLVT.

What is the current consensus analyst rating for Clarivate?

Clarivate currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLVT will outperform the market and that investors should add to their positions of Clarivate.
View the latest ratings for CLVT.

What other companies compete with Clarivate?

Other companies that are similar to Clarivate include Globant, DXC Technology, Five9, Autohome and Pegasystems. Learn More about companies similar to Clarivate.

How do I contact Clarivate's investor relations team?

Clarivate's physical mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The company's listed phone number is 442074334000 and its investor relations email address is [email protected] The official website for Clarivate is www.clarivate.com. Learn More about contacing Clarivate investor relations.